physIQ

Naperville, Illinois, United States All United States companies → — Founded 2005

Clinical AI Platform Wearables / RPM

Cardiology Critical Care Pulmonology

Cardiology AI Wearables & Remote Monitoring (RPM)

Series B

Claim this company

Products

physIQ Heart Rhythm and Respiratory Module

physIQ

Cardiology AI

PhysIQ is the leader in digital medicine, dedicated to generating unprecedented health insight using continuous wearable biosensor data and advanced analytics. Its industry-leading, enterprise-ready cloud platform continuously collects and processes data from any wearable biosensor using a deep portfolio of FDA-cleared analytics.

Contact for pricing

See all 1 product →

About physIQ

physIQ is a healthcare AI company that provides a personalized physiology data analytics platform. Their FDA-cleared algorithms collect and analyze continuously streaming biosensor data to establish a patient’s baseline and detect subtle, yet clinically significant changes in health status. This approach allows for highly personalized insights, moving beyond simple data alerts to provide contextualized information about a patient’s health trajectory.

The company’s technology is designed to transform healthcare delivery from a reactive to a proactive model, acting as an early warning platform rather than a diagnostic tool. These personalized analytics are leveraged to improve clinical trials, at-home patient monitoring, and overall clinical care for individuals with chronic and acute conditions such as heart failure, cancer, and COPD. physIQ’s platform has received FDA 510(k) clearance for its Heart Failure and Atrial Fibrillation detection analytics, as well as its platform for analyzing vital signs.

Focus Areas

Digital Medicine AI-based Personalized Physiology Analytics Continuous Wearable Biosensor Data Remote Patient Monitoring (RPM) Decentralized Clinical Trials Digital Biomarkers Virtual Care Models Post-Acute Care Hospital-at-Home Programs Heart Failure Oncology COPD Viral Infections (e.g. COVID-19)

Business Intelligence

Technology

Enterprise-ready cloud platform, Personalized Physiology Analytics (PPA), AI-based analytics, Deep Neural Network Technology, Data- and device-agnostic platform, Collects data from wearable biosensors (e.g., ECG, triaxial accelerometers), Processes raw telemetry in the cloud, Generates digital biomarkers, pinpointIQ™ (monitoring solution), accelerateIQ™ (for clinical trials), Digital Twin model

What Physicians Need to Know

Digital Medicine & AI-based Personalized Physiology Analytics

physIQ is a leader in digital medicine, leveraging proprietary AI and machine learning algorithms to generate personalized health insights from continuous wearable biosensor data. They create a 'digital twin' for each patient, establishing a unique physiological baseline to detect subtle deviations that may indicate disease exacerbation or changes in health, often before symptoms are apparent.

Continuous Wearable Biosensor Data

The company specializes in collecting and processing continuous, real-time biosensor data from various wearable devices, including smartwatches and patch-based sensors. This device-agnostic approach allows for flexibility in data collection across different clinical studies and healthcare settings.

Remote Patient Monitoring (RPM) & Virtual Care Models

physIQ's platform, pinpointIQ™, enables continuous remote patient monitoring, allowing clinicians to proactively manage high-risk patients at home. This is crucial for expanding hospital capacity and providing care beyond traditional hospital walls, particularly for conditions like heart failure, COPD, and viral infections.

Decentralized Clinical Trials

physIQ's AI-based remote monitoring solution is instrumental in modernizing clinical trials by enabling virtual study designs. This approach improves patient participation and retention, provides continuous data streams for greater insight into treatment effects, and supports the development of new digital biomarkers.

Digital Biomarkers

The company has a deep portfolio of FDA-cleared analytics and digital biomarkers that transform raw biosensor data into actionable clinical insights. They are pioneers in developing, validating, and achieving regulatory approval for AI-based analytics, including a COVID-19 Decompensation Index (CDI) and eVO2Max for cardiopulmonary functional capacity.

Post-Acute Care & Hospital-at-Home Programs

The highly scalable physIQ platform supports real-time post-acute care use cases and hospital-at-home programs, allowing for early detection of subtle physiological changes that may precede adverse events, enabling proactive intervention.

Therapeutic Areas (Heart Failure, Oncology, COPD, Viral Infections)

physIQ's technology is applied across multiple therapeutic areas. For heart failure, their solution can predict hospitalization up to 10 days in advance. In oncology, they work to identify biomarkers that predict adverse reactions to cancer treatments. For COPD and viral infections like COVID-19, their system monitors vital signs for early signs of disease exacerbation and helps develop digital biomarkers for early detection of clinical deterioration.

Physician Tip

For physicians, physIQ offers a powerful tool for proactive patient care and enhanced clinical research. Their personalized physiology analytics provide a 'digital twin' for each patient, establishing individual baselines and detecting subtle, clinically meaningful changes in near real-time, often before symptoms become apparent. This enables earlier intervention and potentially reduces hospital admissions and readmissions. The continuous, real-time data from wearable biosensors offers a more comprehensive understanding of a patient's health status compared to intermittent point measurements. In clinical trials, physIQ's platform facilitates decentralized studies, improving patient engagement and providing richer, continuous data for evaluating treatment safety and efficacy. The FDA-cleared analytics and digital biomarkers provide validated insights, supporting evidence-based decision-making.

physIQ's platform is designed to be device-agnostic, capable of collecting and processing data from various wearable biosensors. Their solution integrates with health system IT platforms, including Electronic Health Records (EHRs), to provide seamless real-time alerts and monitoring for care practitioners. They also collaborate with pharmaceutical companies like Janssen Pharmaceuticals to license their platform for clinical studies and commercial applications across multiple therapeutic areas. Additionally, physIQ partners with clinical research organizations such as Science 37 to enhance clinical trial data collected from connected devices.

Products by physIQ

1 product in the directory

physIQ Heart Rhythm and Respiratory Module

physIQ

Cardiology AI

Contact for pricing

What the Web Says

PhysIQ, a company specializing in AI-powered digital health solutions, receives mixed reviews across its various offerings. The core healthcare AI software is praised for its ability to provide real-time patient insights and remote monitoring, aiming to improve patient outcomes and reduce hospital readmissions. However, 'Physiq Fitness' gyms, a separate entity, and 'PHYSIQ' body contouring treatments, and the 'Phyziq' AI fitness app, have more varied feedback, with some positive experiences regarding equipment and results, but also significant complaints about billing, management, and facility issues.

Overall: Mixed

Strengths

PhysIQ's AI software provides real-time, data-driven insights for healthcare, enabling remote patient monitoring and proactive intervention.
The healthcare AI solution integrates with existing electronic health record (EHR) systems.
PhysIQ has been recognized for its technological advancements in continuous remote patient monitoring (cRPM).
PHYSIQ body contouring treatments are described as comfortable, efficient, and can lead to improved muscle tone and body shape.
Physiq Fitness gyms are noted for good equipment and friendly staff in some locations.
The Phyziq AI fitness app offers personalized training programs based on physique analysis.

Limitations

Some Physiq Fitness gym locations have issues with billing practices and keycard access.
Employee reviews for Physiq Fitness mention inconsistent scheduling, unfair pay, and high-stress environments.
There are complaints about a lack of cleanliness and amenities (e.g., soap, paper towels) at some Physiq Fitness gyms.
Management at Physiq Fitness has been described as having poor communication and favoritism.
The downtown Physiq Fitness location is considered underwhelming compared to others.
One review for Physiq Apparel (a different company) describes it as a scam related to unexpected payments.

Based on reviews from: SoftwareWorld, Reddit, Device Pulse, Business Wire, Indeed.com, Cartessa Aesthetics, YouTube, Trustpilot, Elless Metabolic & Hormone Health, App Store, Google Play

Last updated: 2026-10-18

Videos

News, demos, and interviews about physIQ.

Loading videos...

Videos load interactively. If none appear, search YouTube for physIQ →

View all on YouTube

Press & Coverage

Medical Alley

PhysIQ Saw Significant Adoption of Their AI Technology in 2020

PhysIQ experienced significant adoption of its digital medicine platform in 2020, marked by breakthrough studies, partnerships, and an additional FDA clearance. The company's continuous remote patient monitoring (cRPM) system, pinpointIQ™, was used to monitor frontline healthcare workers and high-risk COVID-19 patients.

2021-01

Business Wire

PhysIQ Recognized as a 2021 Hottest Health Tech Company

PhysIQ was named one of the Hottest Health Tech Companies in Digital Health for the second consecutive year by the Observer, recognized for its advancements in continuous remote patient monitoring (cRPM) and its impact during the COVID-19 pandemic. The company's platform uses biosensor data and FDA-cleared AI analytics to provide personalized patient insights.

2021-01

BioSpace

PhysIQ's Proprietary Personalized Analytics to be Used for COVID-19 Care with Newly Broadened FDA Labeling

PhysIQ announced FDA-sanctioned labeling for its pinpointIQ® continuous remote monitoring system, including its Multivariate Change Index (MCI), for use in the COVID-19 pandemic. This allows for proactive monitoring of homebound patients with or vulnerable to COVID-19 using wearable sensors and machine learning to detect subtle physiological changes.

2020-03

Purdue University News

Purdue-affiliated health technology company physIQ receives $500,000 to advance AI innovations

PhysIQ, a Purdue University-affiliated company, received a $500,000 investment from Purdue Research Foundation's Foundry Investment Fund to advance its AI-powered medical technology. The company is exploring collaborations with Purdue's Weldon School of Biomedical Engineering for signal processing and AI-based data analysis from wearable biosensors.

2020-01

pharmaphorum

physIQ licenses virtual trial tech to Janssen in multi-year deal

PhysIQ has licensed its accelerateIQ™ technology to Johnson & Johnson's Janssen pharma unit in a multi-year deal to investigate the use of wearable sensors in virtual clinical trials. This collaboration aims to scale the use of biosensors for R&D and commercial activities across multiple therapeutic areas.

2021-04

Wearable Technologies

PhysIQ Received FDA Clearance for Algorithm Of Patients' Continuous Ambulatory Respiration Rates

PhysIQ received FDA 510(k) clearance for an algorithm that enables cloud-based analysis of patients' continuous ambulatory respiration rates, adding to its portfolio of FDA-cleared cloud-based analytics. This clearance is crucial for developing further AI analytics in cardiopulmonary physiology.

2019-08

Clinical Trials Arena

US institutions join physIQ's study to create Covid-19 digital biomarker

Intermountain Healthcare, UTHealth, and Rush University Medical Center have joined physIQ's DeCODe study, funded by the NIH, to create an AI-based COVID-19 digital biomarker. This initiative aims to provide early identification of clinical decompensation in high-risk COVID-19 patients.

2021-05

BioSpace

Science 37® and PhysIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices

Science 37 and PhysIQ announced a collaboration to enhance clinical trial data collected from connected devices, leveraging PhysIQ's platform for real-time biosensor data, FDA clearance, and ability to support large global clinical trials. This partnership aims to provide faster access to real-world evidence for evaluating product safety and efficacy.

2022-02

Frequently Asked Questions

What specific problems does physIQ solve for healthcare providers and administrators, particularly in areas like Heart Failure, Oncology, COPD, and viral infections?

physIQ addresses the challenges of proactive patient management in chronic conditions and acute illnesses by leveraging AI-powered personalized physiology analytics. It helps identify subtle physiological changes from continuous wearable biosensor data, enabling early intervention and potentially preventing adverse events in conditions like heart failure, COPD, and for patients with viral infections.

How does physIQ's technology integrate with existing virtual care models, remote patient monitoring (RPM) programs, and hospital-at-home initiatives?

physIQ's platform is designed to seamlessly integrate with and enhance existing virtual care models, RPM programs, and hospital-at-home initiatives. By providing continuous, real-time physiological insights from wearable sensors, it empowers healthcare providers to remotely monitor patients, personalize care plans, and make timely interventions, thereby extending care beyond traditional clinical settings.

What are the key features of physIQ's AI-based personalized physiology analytics, and how do they translate into actionable insights for clinical decision-making?

physIQ's AI-based personalized physiology analytics continuously collect and analyze data from wearable biosensors to establish a personalized baseline for each patient. The platform then identifies deviations from this baseline, which can indicate a worsening condition or an impending clinical event. These insights are presented to clinicians as actionable alerts and trends, supporting proactive clinical decision-making and personalized care.

How does physIQ ensure data security, patient privacy, and regulatory compliance (e.g., HIPAA, FDA) for its digital medicine solutions?

physIQ prioritizes data security and patient privacy, adhering to stringent regulatory standards such as HIPAA. The company's solutions are designed with robust security measures to protect sensitive patient information. Additionally, physIQ's technology and algorithms have undergone rigorous validation and have received necessary regulatory clearances, including FDA 510(k) clearance for certain applications, ensuring their safety and effectiveness in clinical use.

What is physIQ's approach to partnerships and collaborations within the healthcare ecosystem, and how do these benefit healthcare providers and patients?

physIQ actively seeks partnerships and collaborations with various stakeholders across the healthcare ecosystem, including pharmaceutical companies, medical device manufacturers, and healthcare providers. These collaborations aim to integrate physIQ's personalized physiology analytics into broader digital health initiatives, accelerate the development of digital biomarkers, and expand the reach of their technology to ultimately improve patient outcomes and advance precision medicine.

Comparisons

physIQ Heart Rhythm and Respiratory Module vs EchoNext

physIQ Heart Rhythm and Respiratory Module vs PMcardio

physIQ Heart Rhythm and Respiratory Module vs Sleepiz One+

physIQ Heart Rhythm and Respiratory Module vs Cardiomo

When choosing between physIQ Heart Rhythm and Respiratory Module and Cardiomo, physicians should consider their primary focus and patient population. PhysIQ excels in continuous, personalized physiological analytics, leveraging a cloud platform to process data from various wearable biosensors. Its strength lies in establishing individual patient baselines and detecting subtle changes, making it suitable for proactive […]

Related Companies

Suggest an Edit → | Report an issue